381 related articles for article (PubMed ID: 25599668)
21. Newborn screening of mucopolysaccharidosis type I.
Burlina AB; Gragnaniello V
Crit Rev Clin Lab Sci; 2022 Jun; 59(4):257-277. PubMed ID: 35037566
[TBL] [Abstract][Full Text] [Related]
22. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
[TBL] [Abstract][Full Text] [Related]
24. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.
Johnson BA; van Diggelen OP; Dajnoki A; Bodamer OA
Curr Protoc Hum Genet; 2013 Oct; 79():17.14.1-17.14.9. PubMed ID: 24510650
[TBL] [Abstract][Full Text] [Related]
25. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
[TBL] [Abstract][Full Text] [Related]
26. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
Amorín M; Carlin A; Prötzel A
Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome.
Ahmed A; Whitley CB; Cooksley R; Rudser K; Cagle S; Ali N; Delaney K; Yund B; Shapiro E
Mol Genet Metab; 2014 Feb; 111(2):123-7. PubMed ID: 24368159
[TBL] [Abstract][Full Text] [Related]
28. Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.
Clarke LA; Russell CS; Pownall S; Warrington CL; Borowski A; Dimmick JE; Toone J; Jirik FR
Hum Mol Genet; 1997 Apr; 6(4):503-11. PubMed ID: 9097952
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
Tebani A; Zanoutene-Cheriet L; Adjtoutah Z; Abily-Donval L; Brasse-Lagnel C; Laquerrière A; Marret S; Chalabi Benabdellah A; Bekri S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196898
[TBL] [Abstract][Full Text] [Related]
30. [Hurler syndrome: early diagnosis and treatment].
Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
[TBL] [Abstract][Full Text] [Related]
31. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
32. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
[TBL] [Abstract][Full Text] [Related]
33. IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
Ghosh A; Mercer J; Mackinnon S; Yue WW; Church H; Beesley CE; Broomfield A; Jones SA; Tylee K
Hum Mutat; 2017 Nov; 38(11):1555-1568. PubMed ID: 28752568
[TBL] [Abstract][Full Text] [Related]
34. Alpha-l-iduronidase and arylsulfatase B in dried blood spots on filter paper: Biochemical parameters and time stability.
Breier AC; Cé J; Mezzalira J; Daitx VV; Moraes VC; Goldim MPS; Coelho JC
Clin Biochem; 2017 May; 50(7-8):431-435. PubMed ID: 28088454
[TBL] [Abstract][Full Text] [Related]
35. Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H.
Raymond GV; Pasquali M; Polgreen LE; Dickson PI; Miller WP; Orchard PJ; Lund TC
Sci Rep; 2016 Dec; 6():38305. PubMed ID: 27910891
[TBL] [Abstract][Full Text] [Related]
36. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.
Lin SP; Lin HY; Wang TJ; Chang CY; Lin CH; Huang SF; Tsai CC; Liu HL; Keutzer J; Chuang CK
Orphanet J Rare Dis; 2013 Sep; 8():147. PubMed ID: 24053568
[TBL] [Abstract][Full Text] [Related]
37. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
[TBL] [Abstract][Full Text] [Related]
38. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.
Scott CR; Elliott S; Buroker N; Thomas LI; Keutzer J; Glass M; Gelb MH; Turecek F
J Pediatr; 2013 Aug; 163(2):498-503. PubMed ID: 23465405
[TBL] [Abstract][Full Text] [Related]
39. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
Brooks DA
Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
[TBL] [Abstract][Full Text] [Related]
40. Mutation Analysis of the
Kamranjam M; Alaei M
Genet Test Mol Biomarkers; 2019 Aug; 23(8):515-522. PubMed ID: 31298590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
